Many private investors have graciously given positive reviews for StocksHaven Investments’ latest conference call with Hemispherx BioPharma (Public, AMEX:HEB). Due to this, a follow up list providing essentials and guidance for successful conference calls seemed like a great idea. So without further adue, here is Michael Vlaicu’s strategies on championing this task: 1. INTRODUCTION Many [...]



